AAIC 2026: Latin American Prevention Network Grows and Anti-Amyloid Therapies Face Real-World Test
Start here
At AAIC 2026, two strands of Alzheimer's research took center stage. The Latin FINGERS Prevention Network has generated prevention studies across multiple Latin American countries and built a multinational researcher base and infrastructure, which speakers described as an unprecedented opportunity for prevention in the region. In parallel, the conference presented real-world data on the approved anti-amyloid immunotherapies lecanemab and donanemab, examining how the two disease-modifying drugs perform in everyday clinical settings rather than controlled trials. The work sits at the intersection of public health and neuroscience, pairing regional prevention infrastructure with evidence on whether marketed therapies translate into routine practice. What remains open is how far the Latin American network can scale its prevention efforts and how the real-world findings will shape clinical use of both drugs.
Written by a model from the reports · updated 4 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- YouTubeAAIC 2026: Latin FINGERS Prevention Network and Real-World Data on Anti-Amyloid Immunotherapies
Latin FINGERS has produced significant prevention research across multiple Latin American countries and built a multinational researcher network and infrastructure that speakers called an unprecedented opportunity for prevention in the region. AAIC 2026 also highlights how the approved anti-amyloid immunotherapies lecanemab and donanemab perform in real clinical settings rather than controlled trials, adding evidence on whether they translate to practice. The coverage sits at the intersection of public health and neuroscience, focusing on prevention infrastructure and real-world evidence for marketed disease-modifying therapies.
Coverage and heat for this story
Reports so far 1·Heat now 9·Peak heat 10 (Oct 21 00:00)·Reports, 24h +1
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.